OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
45
Results
Show all
Save search
Copy query
Show results for
Unknown
(45)
Publication Date
Release Date
2025
(9)
2020
(7)
2024
(5)
2017
(5)
2021
(4)
2018
(4)
2016
(4)
2015
(2)
2014
(2)
2026
(1)
2023
(1)
2022
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity.
Not available
S-EPMC4050203
|
biostudies-literature
Cite
Perioperative and Maintenance Therapy After First-Line Therapy as Paradigms for Drug Discovery in Urothelial Carcinoma.
Not available
S-EPMC4504799
|
biostudies-literature
Cite
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations.
Not available
S-EPMC5566506
|
biostudies-literature
Cite
Atezolizumab in patients with renal insufficiency and mixed variant histology: analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelial carcinoma.
Not available
S-EPMC7342864
|
biostudies-literature
Cite
Enfortumab Vedotin-related Cutaneous Toxicity and Radiographic Response in Patients with Urothelial Cancer: A Single-center Experience and Review of the Literature.
Not available
S-EPMC9937876
|
biostudies-literature
Cite
Enfortumab vedotin-related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experience.
Not available
S-EPMC11199536
|
biostudies-literature
Cite
Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma.
Not available
S-EPMC12361773
|
biostudies-literature
Cite
Nectin-4 PET for predicting enfortumab vedotin dose-response in urothelial carcinoma.
Not available
S-EPMC12778052
|
biostudies-literature
Cite
Sarcomatoid areas of urothelial carcinoma are enriched for CD163-positive antigen-presenting cells.
Not available
S-EPMC11839278
|
biostudies-literature
Cite
Sparing urethra in women at the time of cystectomy: retrospective comparison of cystectomies with and without urethrectomy.
Not available
S-EPMC12603828
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets